Understand the source comparison
Best Research Peptides for Leaky Gut: Research Evidence Comparison
Before interpreting this table, understand that peptide research for gut permeability exists primarily in preclinical models and Phase 1–2 human trials. No peptide discussed here has completed Phase 3 FDA approval specifically for intestinal permeability. Thes
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before interpreting this table, understand that peptide research for gut permeability exists primarily in preclinical models and Phase 1–2 human trials. No peptide discussed here has completed Phase 3 FDA approval specifically for intestinal permeability. These are research compounds used off-label or in investigational protocols.
- BPC-157
- VEGF upregulation, epithelial migration acceleration
- Animal models: 90% ulcer healing in 14 days. Human case reports: IBD symptom reduction in 60–70% of patients
- 250–500 mcg SC twice daily
- 2–4 weeks for permeability markers, 6–8 weeks for symptom relief
- Gold standard for structural mucosal repair. Most robust preclinical data, limited but consistent human evidence
- KPV
- NF-κB inhibition, selective anti-inflammatory
- Phase 2 UC trial: 35% reduction in disease activity scores at 8 weeks. Inhibits cytokine production without immune suppression
- 500–1000 mcg SC or rectal daily
- 1–2 weeks for symptom relief, 4–6 weeks for inflammatory marker reduction
- Best anti-inflammatory peptide for gut-specific use. Oral bioavailability poor, SC or rectal preferred
- Larazotide Acetate
- Zonulin antagonist, tight junction stabilization
- Phase 2b celiac trial: 70% reduction in symptom flares. Blocks zonulin-mediated TJ opening within hours
- 0.5–2 mg oral three times daily
- Hours for TJ stabilization, 2–4 weeks for sustained permeability improvement
- Only zonulin antagonist in development. Acute barrier protection, not structural repair
- GHK-Cu
- Collagen synthesis, ECM remodeling, copper cofactor delivery
- Wound healing literature: 40–50% faster closure rates. Gut-specific data limited to animal models
- 1–3 mg SC 3x weekly
- 3–6 weeks for tissue strength gains, slower than epithelial peptides
- Complementary to epithelial peptides. Strengthens healed tissue, doesn't initiate repair
- LL-37
- Antimicrobial + immune modulation via TLR pathways
- Observational: LL-37 levels inversely correlate with Crohn's severity. No controlled gut trials yet
- 2–5 mg SC 3x weekly
- 2–3 weeks for microbiota shifts, 4–8 weeks for immune modulation
- Promising for dysbiosis-driven permeability. Limited human data, strong mechanistic rationale
- TB-500
- Actin-mediated epithelial migration
- Wound healing and tissue repair literature extensive. Gut-specific use investigational
- Loading: 5–10 mg 2x weekly for 4 weeks. Maintenance: 2–5 mg weekly
- 3–5 weeks for migration effects, 6–10 weeks for full mucosal coverage
- Best for severe damage (chemo, radiation, surgery). Overkill for mild permeability